Yosprala
- Product NDC
- 68071-5102
- 11-digit product format
- 680715102
- Labeler code
- 68071
- Product ID
- 68071-5102_bbf2a048-2568-7e01-e053-2995a90ad9e2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Yosprala
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- NDA205103
- Marketing category
- NDA
- Marketing start
- 2019-07-17
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN; OMEPRAZOLE
- Active strength
- 81 mg/1; mg/1
- Pharmacologic classes
- Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-5102-0 | 68071510200 | 30 TABLET, FILM COATED in 1 BOTTLE (68071-5102-0) | 2019-11-08 | 0000-00-00 | No | No | Current |